| [1] |
LIU Guiju, YUAN Wei, LYU Dinglin, HAN Qianqian, MEI Jiazhuan, ZHANG Haozhe.
Pristimerin sensitizes human esophageal squamous cell carcinoma cell strain ECA109/DDP to cisplatin
[J]. Basic & Clinical Medicine, 2026, 46(9): 1200-1206.
|
| [2] |
ZHANG Youliang, REN Guangyu, WU Jia, ZHU Haohao.
LINC00339 promotes the migration and invasion of thyroid cancer cell lines by regulating the miR-15b-5p/E2F3 axis
[J]. Basic & Clinical Medicine, 2026, 46(9): 1175-1182.
|
| [3] |
LIU Huoxi, HUANG Botian, ZHAO Yuntao, ZHANG Jiayang, WU Wenmei.
Overexpression of histone deacetylase 4 inhibits proliferation and invasion of colorectal cancer cells
[J]. Basic & Clinical Medicine, 2026, 46(8): 1051-1058.
|
| [4] |
FAN Wenyi, CHEN Yuwei, ZHENG Cuiting, LYU Jiarui, WANG Yanan.
Pifithrin-μ inhibits the proliferation of TSC2 mutant hepatocellular carcinoma cells
[J]. Basic & Clinical Medicine, 2026, 46(8): 1059-1067.
|
| [5] |
QIN Ziyi, XU Yeting, ZOU Jiaming, MA Jinyang, WANG Yucheng, JU Rui, GUO Lei.
Carboxyamidotriazole orotate regulates cancer-associated fibroblasts function and remodels the tumor microenvironment in pancreatic cancer
[J]. Basic & Clinical Medicine, 2026, 46(8): 1068-1075.
|
| [6] |
CHEN Ziran, HUANG Rong, LU Yan, LI Kai, SONG Wei.
Construction and validation of a gemcitabine resistance gene signature based on cholangiocarcinoma organoids
[J]. Basic & Clinical Medicine, 2026, 46(7): 904-912.
|
| [7] |
LI Xianqun, CHI Yuxin, MIAO Jiaming, QI Xiaolu, WEI Tong, YANG Weihong.
Research progress in the regulatory mechanism of tumor-associated intronic enhancer region SNPs
[J]. Basic & Clinical Medicine, 2026, 46(7): 1009-1013.
|
| [8] |
CHEN Weixin.
Analysis of the immune characteristics of peripheral blood lymphocyte subsets in patients with early and advanced non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2026, 46(6): 823-829.
|
| [9] |
LI Shuxiang.
Study on metabolic spatial heterogeneity of hepatocellular carcinoma tumor boundary
[J]. Basic & Clinical Medicine, 2026, 46(6): 815-822.
|
| [10] |
SONG Ning, LUO Junyi, JI Wei, LI Yanhong, LI Xiaomei, YANG Yining.
Knock-down MALAT1 reduces ox-LDL- induced-inflammation and cell damage of macrophages
[J]. Basic & Clinical Medicine, 2026, 46(3): 352-358.
|
| [11] |
SUN Fengqi, YU Yingjie, SONG Yunjia, YANG Jing, ZHAO Weiming.
Progress of research on the role of uncoupling protein 2 in hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2026, 46(11): 1550-1553.
|
| [12] |
ZHANG Yufeng, ZHANG Xinna, ZHOU Yanjiao.
PHLPP2 variation is associated with prognosis as well as ferroptosis in patients of advanced lung adenocarcinoma harboring EGFR+TP53 co-mutations
[J]. Basic & Clinical Medicine, 2026, 46(1): 103-108.
|
| [13] |
AN Xin, JIA Lin, Mawusumu·MAMUT, HUANG Zhipeng, KahrimanI·SLAM, Rexiati·REHEMAN, Hairila·WULAMU, Kerbanjiang·ABULIKIM, Jesur·BATUR.
Effects of ANGPT1 on proliferation,invasion and angiogenesis of mouse prostate cancer cell line RM-1
[J]. Basic & Clinical Medicine, 2025, 45(9): 1165-1172.
|
| [14] |
LI Huangyi, HUANG Daohang, ZHANG Wenyu, HUANG Dingming, HUANG Qichun.
Mannitol promotes the apoptosis ofhuman lung squamous carcinoma cell line NCI-H292
[J]. Basic & Clinical Medicine, 2025, 45(3): 336-340.
|
| [15] |
ZHANG Hui, GAN Shibao, LI Hui, ZHOU Jiaxun, ZHAO Mengqi.
Silencing KRT17 inhibits proliferation of human esophageal squamous cell line KYSE-150
[J]. Basic & Clinical Medicine, 2025, 45(12): 1548-1556.
|